- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Managed Care Quality and Disenrollment in New York SCHIPUsing data from the New York SCHIP program, this study showed that plan disenrollment was not significantly associated with managed care plan quality.
Latest:
A Call for a Statewide Medication Reconciliation ProgramThe authors propose statewide programs that would expand the Prescription Drug Monitoring Program for all medications-not just opiates-in order to reduce outpatient medication errors.
Latest:
The Role of Nurse Practitioners in Primary HealthcareThe potential of nurse practitioners is not being fully realized in primary care medical practices. Consequently, cost and quality gains are not being achieved.
Latest:
Clinical Characteristics and Treatment Patterns Among US Patients With HIVIt is important to take into account individual complexities such as comorbidities and pill burden when selecting antiretroviral therapy regimens for individuals living with HIV.
Latest:
Medicare Advantage Plan Representatives’ Perspectives on Pay for SuccessThis study examined how Medicare Advantage plan representatives perceive the alternative financing model Pay for Success and its potential to address members’ social risk factors.
Latest:
Do Patient or Provider Characteristics Impact Management of Diabetes?Many more patient than provider characteristics are associated with optimal or poor glycemic control and treatment intensification when glycemic control is initially lost.
Latest:
ACOs With Risk-Bearing Experience Are Likely Taking Steps to Reduce Low-Value Medical ServicesExperience with risk-based contracting best predicts active engagement of accountable care organizations in reducing low-value medical services, mainly through physician education and encouraging shared decision making.
Latest:
Key Takeaways for the Management of HIV PrEPA panel of experts share closing thoughts and advice for the management and uptake of HIV PrEP therapy.
Latest:
Role of Pharmaceuticals in Value-Based Healthcare: A Framework for SuccessA framework for the role of pharmaceuticals in value-based healthcare, practical examples from organizations that have made the transition, and implementation considerations.
Latest:
Bridging the Digital Divide: Mobile Access to Personal Health Records Among Patients With DiabetesRacial/ethnic minorities and patients living in poorer neighborhoods were more likely to access their personal health record exclusively with a mobile device.
Latest:
Real-World Economic Value of a 21-Gene Assay in Early-Stage Breast CancerUniversal gene expression profiling of patients with stage II breast cancer resulted in outpatient savings of $11,000 (inclusive of testing costs) within 6 months of initiation of medical therapy.
Latest:
Enhanced Care Coordination Improves HIV Viral Load Suppression RatesEnhanced care coordination in New York City that leveraged surveillance data with a health plan’s Medicaid managed care roster improved its HIV viral load suppression rate.
Latest:
Preferred Roles in Treatment Decision Making Among Patients With Cancer: A Pooled Analysis of Studies Using the Control Preferences ScaleThis pooled analysis assesses preferred roles in treatment decision making, actual roles, and preferred versus actual discordance among 6 studies of patients with cancer.
Latest:
LACE+ Index as a Predictor of 90-Day Plastic Surgery OutcomesPatients with higher LACE+ index scores have significantly greater risk of unplanned readmission, emergency department visits, and reoperation after plastic surgery.
Latest:
Antibiotic Use for Viral Acute Respiratory Tract Infections Remains CommonAntibiotic use for acute respiratory tract infections that are largely viral remains common. Macrolide use has increased since 2007, and 9% of patients received a second antibiotic within 30 days.
Latest:
Implications of Evolving Delivery System Reforms for Prostate Cancer CareHealthcare integration was associated with small declines in treatment, but no change in overtreatment of prostate cancer. Integrated care delivery alone may be insufficient to curtail overtreatment.
Latest:
Cost Analysis of COPD Exacerbations and Cardiovascular Events in SUMMITThis cost analysis using data from the Study to Understand Mortality and Morbidity in COPD (SUMMIT) trial found that fluticasone furoate/vilanterol reduced the rates and costs of combined chronic obstructive pulmonary disease (COPD) exacerbations and revascularization/cardiovascular events versus placebo.
